
Ashay D. Bhatwadekar, PhD
Glick Family Professor of Ophthalmology Research
Professor of Ophthalmology
Professor of Biochemistry, Molecular Biology & Pharmacology
Bio
Ashay Bhatwadekar, PhD, is a Glick Family Professor of Ophthalmology Research at the Indiana University School of Medicine, Department of Ophthalmology, with a secondary appointment in the Department of Biochemistry, Molecular Biology & Pharmacology. He is an adjunct Professor of the Department of Pharmacy Practice, College of Pharmacy, Purdue University. He is also a licensed pharmacist in the State of Indiana. At the Eugene and Marilyn Glick Eye Institute, he works to better understand the disease and develop new treatments for diabetic retinopathy, the most common complication of long-term diabetes.
A routine eye exam put Dr. Bhatwadekar on the path to researching diabetic retinopathy—a diabetic condition in which fluid and blood leaking from blood vessels in the eye damage the retina. When his optometrist told him there was no cure, he was inspired to study the condition and its implications.
Dr. Bhatwadekar's academic journey began in India at Amravati University, where he earned a Bachelor of Science in pharmacy. He then pursued his doctorate in biomedical science at Queen’s University Belfast, gaining a diverse international perspective. His postdoctoral experience at the University of Florida further enriched his knowledge before he joined the IU School of Medicine.
Dr. Bhatwadekar's research interests are diverse and impactful. In addition to investigating diabetic retinopathy, he studies retinal Müller cell dysfunction and how circadian rhythm disruption affects vision. His laboratory has achieved significant breakthroughs, including mapping the biorhythm of Müller glial potassium channels, identifying visual dysfunction caused by circadian rhythm disruption, and developing a gene therapy for diabetic retinopathy. Given the scarcity of blood-based biomarkers for early diagnosis of diabetic retinopathy, his laboratory combines transcriptomics, miRNomics, and artificial intelligence to identify at-risk individuals. He has also expanded his research into ocular neuroscience, examining Alzheimer's disease and its effects on ocular health. In comorbidities such as Alzheimer's disease, the eye serves as a transparent window through which researchers can study brain changes that would otherwise be obscured by the skull.
His work has received recognition and support through grants from prestigious organizations, including the NIH/NEI, the International Retinal Research Foundation, and the Showalter Research Trust. He has been named an August M. Watanabe Translational Scholar, an IU School of Medicine Showalter Scholar, and an Association of Research for Vision and Opthalmology’s Gold and Silver Fellow. He has also contributed to the field by serving on federal and charitable trust review panels and reviewing manuscripts for numerous journals focused on diabetes and eye research.
| Year | Degree | Institution |
|---|---|---|
| 2007 | PhD | Queen's University of Belfast |
| 1999 | MPHARM | University of Pune |
| 1997 | BPHARM | Amravati University |